Jennifer R Riggs
6PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 24, 2025
Discovery and Characterization of Novel BLIMP-1 Heterobifunctional Ligand-Directed Degraders.Bryan J Simmons, Lynda Groocock, Jesus Moreno
|Sep 25, 2025
Application of Weighted Interaction-Fingerprints for Rationalizing Neosubstrate Potency and Selectivity of Cereblon-Based Molecular Glues.Guilian Luchini, Shuang Liu, Hannah L Powers
|Mar 06, 2025
Leveraging efficiency metrics for the optimization of CELMoDs™ as cereblon-based molecular glue degraders.Lei Jia, Jennifer R Riggs, Dahlia R Weiss
|Aug 30, 2021
Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity.Jan Elsner, Dan Cashion, Dale Robinson
|Apr 19, 2019
Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy.Jennifer R Riggs, Jan Elsner, Dan Cashion
|Oct 10, 2017
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen.Jennifer R Riggs, Mark Nagy, Jan Elsner
Pageof 1
Frequent Collaborators
2 joint publications
Christoph W Zapf
2 joint publications
Lihong Shi
1 joint publications
Philip P Chamberlain
1 joint publications
Kevin Condroski
1 joint publications
Jan Elsner
1 joint publications
Lei Jia
1 joint publications
Dahlia R Weiss
1 joint publications
Veerabahu Shanmugasundaram
1 joint publications
Guilian Luchini
1 joint publications
Joel W Thompson
